• Accueil >
  • Publications >
  • Final overall survival analysis of a phase II trial evaluating vinorelbine and lapatinib in women with ErbB2 overexpressing metastatic breast cancer

Final overall survival analysis of a phase II trial evaluating vinorelbine and lapatinib in women with ErbB2 overexpressing metastatic breast cancer

1 déc. 2015The Breast

DOI : 10.1016/j.breast.2015.08.005

Auteurs

Wolfgang Janni, Tomasz Sarosiek, Boguslawa Karaszewska, Joanna Pikiel, Elzbieta Staroslawska, Piotr Potemski, Christoph Salat, Etienne Brain, Christian Caglevic, Kathryn Briggs, Kim Mahood, Michelle DeSilvio, Luca Marini, Christos Papadimitriou